PEDAL TO THE METAL FOR CHARITY

DIBBSBARKER has used pedal power to raise close to $40,000 for cancer research.

The law firm participated in the Rio Tinto Ride to Conquer Cancer, marking the fifth consecutive year that the firm has been involved in the annual Brisbane fundraiser in support of cancer research at the QIMR Berghofer Medical Research Institute.

Collectively, riders in this year's event raised $2.9 million, bringing the total raised over the past five years to more than $20 million.

"The Rio Tinto Ride to Conquer Cancer is a wonderful event that we are proud to have been involved with every year since its inception in 2011," says Penny Murray, partner and head of DibbsBarker's DibbsREACH community involvement program.

"With cancer being a disease that sadly affects almost all of us in one way or another, this is a great opportunity for members of our firm to join forces with so many others who want to see a cancer-free future, and help contribute to a great cause."

QIMR Berghofer uses the funds raised by the ride to power life-saving cancer research programs, enable the continuity of promising studies, acquire new equipment and retain experts to lead this vital work.

The DibbsBarker's team compromised 11 riders who pushed the pedals around the 220 kilometre course, backed by 22 crew members who provided support.

Professor Frank Gannon, Director and CEO of the QIMR Berghofer Medical Research Institute, says he is incredibly grateful for the efforts of the DibbsBarker team in this year's event, and over the five years of the Rio Tinto Ride to Conquer Cancer.

"After 1000 shared kilometres we have many warm memories of their involvement in the ride, and tremendous respect for the contribution they have made to our research into better ways to prevent, diagnose and treat cancers.

"Our researchers are greatly encouraged by the enthusiasm and commitment shown. Over the past five years DibbsBarker has become a valued part of the Institute family and we look forward to continuing to work with them in the future."

QIMR Berghofer is home to more than 600 scientists and staff whose research efforts are focused on cancer as well as infectious diseases, mental health and a range of complex disorders.

QIMR Berghofer's aim is to improve health by developing new diagnostics, better treatments and prevention strategies.

Picture L-R: Matthew Rollason (DibbsBarker), Louise Ridley (DibbsBarker), Duncan Ferguson (Uniquest), James Dickson (KPMG), Emma Sleddon (DibbsBarker), Michael Hodgson (DibbsBarker), Matthew Jesse (PPB Advisory), Kristen Wallace (DibbsBarker)